Not much relevance to AS, although the "by the book, standard of care" may explain some of the above.
Possibly. I guess I am not going to make a big deal that a doctor, representing a facility, prefers to speak about
those treatment modalities available at his
location. That is fair, but I feel that he should mention the others as being treatments you could look into, but would need to go elsewhere for them. I also take issue with his declaring SBRT as "to be used only in clinical trials." That is just wrong.
Age 68 at Dx
PSA history: 2000-2012 0.9-1.2; 06/2012 started T replacement
2013-2015 3.0-3.3 (new normal)
Biopsy: 12-core biopsy 07/2016; 3 cores G3+3, 5% or less; 1 core 3+4, 15%; 1 core HGPIN; 2% of gland involved. Summary G3+4.